n-3 Fatty acids (fish oil) for epilepsy, cardiac risk factors, and risk of SUDEP: Clues from a pilot, double-blind, exploratory study

Epilepsy and Behavior

Volumn 13, Issue 4, 2008, Pages 681-684

  DeGiorgio, Christopher M ^a   Miller, Patrick ^a   Meymandi, Sheba ^a   Gornbein, Jeffrey A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DHA; EPA; Epilepsy; Heart rate variabiity; n 3 Fatty acids; PUFA; Seizures; Sudden death; SUDEP

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; HIGH DENSITY LIPOPROTEIN; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; EXPLORATORY RESEARCH; FEMALE; HEART DISEASE; HEART RATE VARIABILITY; HUMAN; INTRACTABLE EPILEPSY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RR INTERVAL; SUDDEN DEATH;

CROSS-SECTIONAL STUDIES; DEATH, SUDDEN, CARDIAC; DOUBLE-BLIND METHOD; EPILEPSY; FATTY ACIDS, OMEGA-3; HEART RATE; HUMANS; PILOT PROJECTS; RISK FACTORS; STATISTICS, NONPARAMETRIC;

EID: 54049138751     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.08.001     Document Type: Article

References (22)

1. Walczak T.S., Leppik I.E., D'Amelio M., et al. Incidence and risk factors in sudden unexpected death in epilepsy. Neurology 56 (2001) 519-525
2. Kloster R., and Torstein E. Sudden unexpected death in epilepsy (SUDEP): a clinical perspective and a search for risk factors. J Neurol Neurosurg Psychiatry 67 (1999) 439-444
3. Langan Y., Nashef L., and Sander J. Case-control study of SUDEP. Neurology 64 (2005) 1131-1133
4. Nashef L., Hindocha N., and Makoff A. Risk factors in sudden death in epilepsy (SUDEP): the quest for mechanisms. Epilepsia 48 (2007) 859-871
5. Ficker D.M., So E.L., Shen W.K., et al. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 51 (1998) 1270-1274
6. Rugg-Gunn F., Simister R., Squirrell M., Holdright D.R., and Duncan J.S. Cardiac arrhythmias in focal epilepsy: a prospective long-term study. Lancet 364 (2004) 2212-2219
7. Frysinger R.C., Engel J., and Harper R.M. Interictal heart rate patterns in partial seizure disorders. Neurology 43 (1993) 2136-2139
8. Ansakorpi H., Korpelainen J.T., Huikuri H.V., et al. Heart rate dynamics in refractory and well controlled temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 72 (2002) 26-30
9. Persson H., Kumlein E., Ericson M., and Tomson T. Preoperative heart rate variability in relation to surgery outcome in refractory epilepsy. Neurology 65 (2005) 1021-1025
10. Ronkainen E., Ansakorpi H., Huikuri H., et al. Suppressed circadian heart rate dynamics in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 76 (2005) 1382-1386
11. Christensen J.H., Gustenhoff P., Korup E., et al. Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomized controlled trial. Br Med J 312 (1996) 677-678
12. O'Keefe J.H., Abuissa H., Stenhaur D.M., and Harris W.S. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol 97 (2006) 1127-1130
13. GISSI-Prevenzione I. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI Prevenzione trial. Lancet 354 (1999) 447-455
14. Sellmayer A., Witzgall H., Lorenz R.L., and Weber P.C. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol 76 (1995) 974-977
15. Singer P., and Wirth M. Can n-3 PUFA reduce cardiac arrhythmias? Results of a clinical trial. Prostaglandins Leukot Essent Fatty Acids 71 (2004) 153-159
16. Geelen A., Brouwer I.A., Schouten E.G., et al. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr 81 (2005) 416-420
17. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043-65.
18. O'Donoghue M., Duncan J., and Sander J. The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. Epilepsia 37 (1996) 563-571
19. Yuen A.W., Sander J.W., Fluegel D., et al. Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav 7 (2005) 253-258
20. Bromfield E., Dworetzsky B., Huwitz S., et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav 12 (2008) 187-190
21. Kris-Etherton P.M., Harris W.S., and Appel L.J. For the AHA Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106 (2002) 2747-2757
22. Peet M., and Horrobin D.F. A dose ranging study of the effects of ethyl-eicosapentanenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry 59 (2002) 913-919